2019
DOI: 10.1007/s10072-019-04167-w
|View full text |Cite
|
Sign up to set email alerts
|

Performance at the clock drawing test of individuals affected by Parkinson’s disease and healthy subjects: a retrospective study

Abstract: Clock Drawing Test (CDT) is a screening tool used in neuropsychological assessment for evaluating comprehensively different cognitive functions. Aberrant performance at CDT was observed in Parkinson's disease, due to impaired executive functioning as well as visuo-spatial difficulties. However, previous studies suffered of different limitations, such reduced sample size and absence of comparison with healthy individuals. The aim of this retrospective study was to verify CDT accuracy in discriminating between 2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 25 publications
0
3
0
Order By: Relevance
“…However, due to its complexity, EF is also reflected in this test ( 110 112 ). Using the clock drawing test, PD patients manifested a low performance compared with healthy controls ( 113 ). However, the major reason for clock drawing difficulties in PD with early cognitive impairment is dysfunctional executive control of memory retrieval instead of visuospatial impairment ( 114 ).…”
Section: Discussionmentioning
confidence: 99%
“…However, due to its complexity, EF is also reflected in this test ( 110 112 ). Using the clock drawing test, PD patients manifested a low performance compared with healthy controls ( 113 ). However, the major reason for clock drawing difficulties in PD with early cognitive impairment is dysfunctional executive control of memory retrieval instead of visuospatial impairment ( 114 ).…”
Section: Discussionmentioning
confidence: 99%
“…As classic assessment tools, CDT and CCT are widely used in the assessment of PD patients because they are easy to understand and requiring less time (Scarpina et al, 2020;Mori et al, 2021;Srivastava et al, 2022). However, their limitations and shortcomings are also obvious.…”
Section: Discussionmentioning
confidence: 99%
“…Val66Met polymorphism; see Supplementary Material for protocols), and cognitive function evaluated with the Mini Mental Parkinson's (MMP; cognitive screening tool that measures attention, conceptualisation, construction, initiation/perseveration and memory, and has a maximum score of 32), the Trail Making test A and B (TMT-A and TMT-B; tests of psychomotor speed, visual attention and task switching) and the Clock Drawing test (CDT; cognitive screening tool that measures spatial dysfunction and neglect) [20][21][22].…”
Section: Data Collectionmentioning
confidence: 99%